430 related articles for article (PubMed ID: 23133802)
21. Oncologic PET tracers beyond [(18)F]FDG and the novel quantitative approaches in PET imaging.
Kumar R; Dhanpathi H; Basu S; Rubello D; Fanti S; Alavi A
Q J Nucl Med Mol Imaging; 2008 Mar; 52(1):50-65. PubMed ID: 18235421
[TBL] [Abstract][Full Text] [Related]
22. Searching for diagnostic properties of novel fluorine-18-labeled D-allose.
Toyohara J; Yamamoto H; Tago T
Ann Nucl Med; 2019 Nov; 33(11):855-865. PubMed ID: 31471865
[TBL] [Abstract][Full Text] [Related]
23. Systematically evaluating DOTATATE and FDG as PET immuno-imaging tracers of cardiovascular inflammation.
Toner YC; Ghotbi AA; Naidu S; Sakurai K; van Leent MMT; Jordan S; Ordikhani F; Amadori L; Sofias AM; Fisher EL; Maier A; Sullivan N; Munitz J; Senders ML; Mason C; Reiner T; Soultanidis G; Tarkin JM; Rudd JHF; Giannarelli C; Ochando J; Pérez-Medina C; Kjaer A; Mulder WJM; Fayad ZA; Calcagno C
Sci Rep; 2022 Apr; 12(1):6185. PubMed ID: 35418569
[TBL] [Abstract][Full Text] [Related]
24.
Werner RA; Derlin T; Lapa C; Sheikbahaei S; Higuchi T; Giesel FL; Behr S; Drzezga A; Kimura H; Buck AK; Bengel FM; Pomper MG; Gorin MA; Rowe SP
Theranostics; 2020; 10(1):1-16. PubMed ID: 31903102
[TBL] [Abstract][Full Text] [Related]
25. β -[
Kumar P; Roselt P; Reischl G; Cullinane C; Beiki D; Ehrlichmann W; Binns D; Naimi E; Yang J; Hicks R; Machulla HJ; Wiebe LI
Curr Radiopharm; 2017; 10(2):93-101. PubMed ID: 28294075
[TBL] [Abstract][Full Text] [Related]
26. Pyrazoles as Key Scaffolds for the Development of Fluorine-18-Labeled Radiotracers for Positron Emission Tomography (PET).
Gomes PMO; Silva AMS; Silva VLM
Molecules; 2020 Apr; 25(7):. PubMed ID: 32283680
[TBL] [Abstract][Full Text] [Related]
27. It's Not What You Take Up, It's What You Keep: How Discoveries from Diverse Disciplines Directed the Development of the FDG PET/CT Scan.
Kaunitz JD; Mandelkern M; Fowler JS
Dig Dis Sci; 2022 Oct; 67(10):4620-4632. PubMed ID: 35908123
[TBL] [Abstract][Full Text] [Related]
28. Magnetic resonance imaging (MRI) for the assessment of myocardial viability: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(15):1-45. PubMed ID: 23074392
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and preliminary in vivo evaluation of new [
Collet C; Schmitt S; Maskali F; Clément A; Chrétien F; Karcher G; Marie PY; Poussier S; Lamandé-Langle S
Bioorg Med Chem; 2017 Oct; 25(20):5603-5612. PubMed ID: 28893600
[TBL] [Abstract][Full Text] [Related]
30. Synthetic methodologies and PET imaging applications of fluorine-18 radiotracers: a patent review.
Nerella SG; Bhattacharya A; Thacker PS; Tulja S
Expert Opin Ther Pat; 2022 Apr; 32(4):455-473. PubMed ID: 35072592
[TBL] [Abstract][Full Text] [Related]
31. The use of fluorine-18 fluorodesoxyglycose-positron emission tomography for treatment monitoring in patients with soft tissue sarcomas.
Kasper B; Hohenberger P; Strauss LG; Dimitrakopoulou-Strauss A
Hell J Nucl Med; 2010; 13(1):40-4. PubMed ID: 20411170
[TBL] [Abstract][Full Text] [Related]
32. Melanoma Imaging Using
Zhang C; Zhang Z; Lin KS; Lau J; Zeisler J; Colpo N; Perrin DM; Bénard F
Mol Pharm; 2018 Jun; 15(6):2116-2122. PubMed ID: 29714486
[TBL] [Abstract][Full Text] [Related]
33. Radiosynthesis and
Bdair H; Singleton TA; Ross K; Jolly D; Kang MS; Aliaga A; Tuznik M; Kaur T; Yous S; Soucy JP; Massarweh G; Scott PJH; Koeppe R; Spadoni G; Bedini A; Rudko DA; Gobbi G; Benkelfat C; Rosa-Neto P; Brooks AF; Kostikov A
ACS Chem Neurosci; 2022 May; 13(9):1382-1394. PubMed ID: 35420022
[TBL] [Abstract][Full Text] [Related]
34. Advances in [
Francis F; Wuest F
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770885
[TBL] [Abstract][Full Text] [Related]
35.
Waldmann CM; Kopka K; Wagner S
Recent Results Cancer Res; 2020; 216():283-318. PubMed ID: 32594390
[TBL] [Abstract][Full Text] [Related]
36. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
Vallabhajosula S
Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
[TBL] [Abstract][Full Text] [Related]
37. Metabolism of a Bioorthogonal PET Tracer Candidate [
Otaru S; Niemikoski H; Sarparanta M; Airaksinen AJ
Mol Pharm; 2020 Aug; 17(8):3106-3115. PubMed ID: 32539414
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
